Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment (NCT02754752) | Clinical Trial Compass
Active — Not RecruitingPhase 2
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
United States111 participantsStarted 2016-09-13
Plain-language summary
This randomized phase II trial studies how well electroacupuncture therapy works in reducing chronic pain in patients following surgery for stage I-III breast cancer. Electroacupuncture therapy is a type of complementary integrative medicine in which pulses of weak electrical current are sent through very thin, solid, sterile, stainless steel needles into certain points in the skin. Electroacupuncture therapy may help to lower pain and other surgery-related symptoms.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be adult women \>/= 18 years of age.
* Be able to read, write, and speak English
* Able to give informed consent
* Have a history of stage I, II, or III breast cancer
* Have a documented visit with an oncologist during the previous 12-months
* Have no current evidence of disease
* Have persistent pain (unrelated to aromatase inhibitors or chemotherapy-induced peripheral neuropathy) for at least 3 months following treatment for breast cancer
* Have pain severity (arithmetic mean of four pain severity items) \>= 2 on Brief Pain Inventory (BPI)
* Have worst pain \>= to 4 (0-10 numeric rating scale \[NRS\]) in the preceding week
* Be willing and able to adhere to all study-related procedures
* Have completed all cancer treatment (including surgery, chemotherapy and/or radiation) at least 4 months prior to enrollment
* Have documented lab work with absolute neutrophil count (ANC) \>= 1.0 K/uL and platelets \>= 50 K/uL in the past 12 months
* If applicable, maintain self-management of lymphedema symptoms being performed at home at time of study entry
Exclusion Criteria:
* Metastatic breast cancer (stage IV)
* Known bleeding disorder per patient reported history
* Cardiac pacemaker or other implanted electronic devices
* New or planned new lymphedema treatment during the study period
* Currently receiving or ever received acupuncture for present pain condition
* Received acupuncture with electrical stimulation for any condition
* Received acupuncture for any…
What they're measuring
1
Change in pain scores assessed by Brief Pain Inventory (BPI)